Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Heart Rhythm|April 22, 2018
Left ventricular regional remodeling and lead position during cardiac resynchronization therapyMads Brix Kronborg, Anders Sommer, Daniel B Fyenbo, et al.
Kidney International|October 21, 2022
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathyJonathan Barratt, Richard Lafayette, Jens Kristensen, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|March 29, 2022
Cardiac computed tomography-verified right ventricular lead position and outcomes in cardiac resynchronization therapyDaniel Benjamin Fyenbo, Anders Sommer, Charlotte Stephansen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2007
The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humansAnders Berkenstam, Jens Kristensen, Karin Mellström, et al.
Lancet (London, England)|August 17, 2023
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trialRichard Lafayette, Jens Kristensen, Andrew Stone, et al.
The Lancet. Haematology|April 24, 2021
Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialBart J Biemond, Anil Tombak, Yurdanur Kilinc, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 6, 2019
Electrically vs. imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trialCharlotte Stephansen, Anders Sommer, Mads Brix Kronborg, et al.
Heart Rhythm O2|September 12, 2024
Repeat ablation of atrial fibrillation using electrogram dispersion to identify additional areas of mechanistic significanceJunaid A B Zaman, Abdulhaseeb Khan, Jan Nielsen, et al.
European Journal of Heart Failure|April 19, 2016
Multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trialAnders Sommer, Mads Brix Kronborg, Bjarne Linde Nørgaard, et al.
International Journal of Cardiology|March 1, 2021
Discontinuation of oral anticoagulation and risk of stroke and death after ablation for typical atrial flutter: A nation-wide Danish cohort studyMikkel Giehm-Reese, Martin Nygård Johansen, Mads Brix Kronborg, et al.
Pageof 6